Gefitinib in combination with DNA topoisomerase I inhibitor CPT-11 exerts a powerful anti-cancer effect via the activation of apoptosis and the inhibition of EGFR phosphorylation in vitro and in vivo [53]. The gene discussed is EGFR; the disease is cancer.